Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation (HAPPY)

November 2, 2021 updated by: Aarhus University Hospital

Return to Everyday Life After Non-myeloablative Allogeneic Haematopoietic Stem Cell Transplantation; Feasibility and Participants' Perspectives of a Targeted Multimodal Interdisciplinary Rehabilitation Programme (HAPPY)

Non-myeloablative allogeneic haematopoietic stem cell transplantation (NMA-HSCT) is associated with innumerable complications and side-effects and a high treatment-related mortality. Maintaining quality of life, physical and psychosocial functioning and participation in society is therefore challenging for patients undergoing treatment with NMA-HSCT. This situation creates an urgent need for rehabilitation for patients to return to a meaningful everyday life, and for knowledge about how to best help this group of patients return to everyday life.

The project aims to develop and examine the feasibility and safety of a multimodal interdisciplinary rehabilitation programme targeted patients undergoing treatment with NMA-HSCT.

Three studies are planned. Study I is a qualitative interview study to get a profound insight into patients' experiences and challenges after NMA-HSCT.

Study II has a single arm longitudinal design with both a feasibility and an outcome component. Patients (N=30) are consecutively recruited at the Department of Haematology, Aarhus University Hospital, Denmark and enrolled in the 6-month HAPPY programme as soon as the decision about NMA-HSCT is final. Data is collected pre-NMA-HSCT, at 3-month, 6-month and 12-month after NMA-HSCT.

Study III is a qualitative interview study, where patients who participated in the rehabilitation programme evaluate the programme's influence on their return to everyday life.

The project contributes with knowledge about the feasibility of a rehabilitation programme targeted at a vulnerable group of chronic cancer patients with rare diseases. We will document the impact of an interdisciplinary intervention anchored in the hospital setting but aimed at reaching patients at home. If the intervention enhances quality of life, patient activation and functioning, it may not only reduce the number of hospitalizations and use of healthcare services, but may also allow more patients to maintain contact with the labour market and resume participation in society.

Study Overview

Detailed Description

Rehabilitation is becoming increasingly important in the face of growing diversity and intensity of cancer treatment and so is treatment with haematopoietic stem cell transplantation from a donor. Non-myeloablative allogeneic haematopoietic stem cell transplantation (NMA-HSCT) is associated with innumerable complications and side-effects and a high treatment-related mortality. Maintaining quality of life, physical and psychosocial functioning, and participation in society is therefore challenging for patients undergoing treatment with NMA-HSCT. This situation creates an urgent need for rehabilitation for patients to return to a meaningful everyday life, and for knowledge about how to best support this group of patients' return to everyday life.

The overall aim is to develop and evaluate the feasibility of a targeted multimodal interdisciplinary rehabilitation programme by involving patients undergoing NMA-HSCT.

Three studies were planned in accordance with the theoretical framework of Complex Interventions.

Study I is a qualitative focus group interview study using the Interpretive Description methodology. The purpose was to explore the experiences and perspectives of NMA-HSCT patients regarding their challenges and needs during their return to everyday life after HSCT transplantation.

Study II has a single arm longitudinal design with both a feasibility component and an outcome component.

The aim was to develop and to assess feasibility of the multimodal interdisciplinary rehabilitation programme HAPPY in patients with haematological cancers undergoing NMA-HSCT. Furthermore, to report health related quality of life, Patient Activation Measurement, cardiorespiratory capacity (VO2peak), muscle extension power, lean body mass, days at hospital, return to work and survival. A 6-month multimodal interdisciplinary rehabilitation programme was tested. The programme consisted of motivating interviewing technique, individual supervised physical exercise training, relaxation exercises, nutritional counselling, and group sessions (a combination of topics and exchange of experiences) with patients and relatives. To reach patients at home, the team phoned patients, who were also given tablets with access to the project's homepage and a digital physical exercise programme. Feasibility parameters were acceptability, exposure, fidelity, practicality, safety

Study III is a qualitative interview study using the Interpretive Description methodology. The aim was to explore patients' experiences and perspectives on relevance and meaning of participating in the multimodal interdisciplinary rehabilitation programme HAPPY, and the programme's influence on handling everyday life, during and after NMA-HSCT.

The project contributes with knowledge about the feasibility of a rehabilitation programme targeted at a vulnerable group of chronic cancer patients with rare diseases. We will document the impact of an interdisciplinary intervention anchored in the hospital setting but aimed at reaching patients at home. If the intervention enhances health related quality of life, patient activation and functioning, it may not only reduce the number of hospitalizations and use of healthcare services, but may also allow more patients to maintain contact with the labour market and resume participation in society.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aarhus, Denmark
        • Dep. of Hem. Aarhus Universitetshospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients were accepted for NMA-HSCT
  • ≥ 18 years
  • able to read and understand Danish and to follow the study protocol.

Exclusion Criteria:

  • psychological diagnosis
  • contra-indications for progressive exercise training
  • inability to walk or stand
  • instable bone lesions
  • severe neurological deficiencies
  • severe cardiac or cardio vascular diseases, severe pulmonary global insufficiency.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: HAPPY
Single arm longitudinal design.
A 6-month multimodal interdisciplinary rehabilitation programme abbreviated HAPPY was tested. The programme consisted of motivating interviewing technique, individual dialogues with fixed subjects, individual supervised physical exercise training, relaxation exercises, nutritional counselling, and group sessions (a combination of topics and exchange of experiences) with patients and relatives. To reach patients at home, the team phoned patients, who were also given tablets with access to the project's homepage and a digital physical exercise programme.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: Baseline - 6-month follow-up
Number of patients who accepted to participate in the study out of patients treated with non-myeloablative allogeneic haematopoietic stem cell transplantation
Baseline - 6-month follow-up
Attrition and reasons for drop out
Time Frame: Baseline - 6-month follow-up
Number of drop-outs of patients participating in the study
Baseline - 6-month follow-up
Exposure to physical exercise training per patient
Time Frame: Baseline - 6-month follow-up
The percentage of physical exercise training used by the patients when he/she was at the hospital and reason(s) for non-participation
Baseline - 6-month follow-up
Exposure to motivating interviewing per patient
Time Frame: Baseline - 6-month follow-up
The percentage of motivating interviewing used by the patients out all planned, and reason(s) for non-participation
Baseline - 6-month follow-up
Exposure to group sessions topics together with fellow patients and relatives per patient
Time Frame: Baseline - 6-month follow-up
The percentage of group sessions with different topics used by the patients out all planned, and reason(s) for non-participation
Baseline - 6-month follow-up
Exposure to nutritional counselling per patient
Time Frame: Baseline - 6-month follow-up
The percentage of nutritional counselling used by the patients out of planned, and reason(s) for non-participation
Baseline - 6-month follow-up
Exposure to digital physical exercise programme per patient
Time Frame: Baseline - 6-month follow-up
The percentage usage of the digital exercise programme out of possible/planned digital exercise trainings, and reason(s) for non-participation
Baseline - 6-month follow-up
Exposure to phone calls to patients staying at home
Time Frame: Baseline - 6-month follow-up
The percentage use of phone calls by patients while they stay at home, and reason(s) for unused
Baseline - 6-month follow-up
Exposure to individual dialogues
Time Frame: Baseline - 6-month follow-up
The percentage of individual dialogues with fixed subjects used by the patients out all planned, and reason(s) for non-participation
Baseline - 6-month follow-up
Adverse Events
Time Frame: Baseline-1-year follow-up
The number of adverse events related to the intervention
Baseline-1-year follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fidelity of physical exercise training
Time Frame: Baseline - 6-month follow-up
The percentage of physical exercise trainings delivered as planned, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of motivating interviewing
Time Frame: Baseline - 6-month follow-up
The percentage of motivating interviewing delivered as planned, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of individual dialogues
Time Frame: Baseline - 6-month follow-up
The percentage of individual dialogues with fixed subjects delivered as planned, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of group sessions
Time Frame: Baseline - 6-month follow-up
The percentage of group sessions with different topics and exchange of experiences delivered as planned, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of nutritional counselling
Time Frame: Baseline - 6-month follow-up
The percentage of nutritional counselling delivered out of planned, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of the digital exercise programme
Time Frame: Baseline - 6-month follow-up
The percentage delivery of the digital exercise programme out of planned digital exercise trainings, and reason(s) for cancellation
Baseline - 6-month follow-up
Fidelity of delivered phone calls
Time Frame: Baseline - 6-month follow-up
The percentage of delivered phone calls to patients at home, , and reason(s) for cancellation
Baseline - 6-month follow-up
Practicability of questionnaires and physical tests
Time Frame: Baseline-1-year follow-up
Percentage of questionnaires and physical tests performed out of possible questionnaires and physical tests, and reason(s) for delay or cancellation
Baseline-1-year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Astrid Lindman, Aarhus Universitetshospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

January 15, 2021

Study Completion (Actual)

July 1, 2021

Study Registration Dates

First Submitted

February 23, 2021

First Submitted That Met QC Criteria

March 10, 2021

First Posted (Actual)

March 15, 2021

Study Record Updates

Last Update Posted (Actual)

November 10, 2021

Last Update Submitted That Met QC Criteria

November 2, 2021

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • HAPPY-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stem Cell Transplantation

Clinical Trials on Multimodal interdisciplinary rehabilitation programme (HAPPY)

Subscribe